Seroprevalence of serum HBSAg positivity and hepatitis delta virus infection among blood donors in Southeastern Turkey

Clinica Terapeutica

Volumn 165, Issue 2, 2014, Pages 95-98

  Mese, S ^a   Nergiz, S ^a   Tekes, S ^a   Gul, K ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Anti delta antibody; Blood donors; Hbsag; HDV RNA; Hepatitis D virus

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS ANTIBODY; VIRUS RNA;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; DELTA AGENT HEPATITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS DELTA VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING TEST; SEROPREVALENCE; TURKEY (REPUBLIC); BLOOD; COMPLICATION; HEPATITIS B, CHRONIC; TURKEY;

ADULT; BLOOD DONORS; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HEPATITIS D, CHRONIC; HUMANS; MALE; PROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; TURKEY;

EID: 84925873227     PISSN: 00099074     EISSN: 19726007     Source Type: Journal    
DOI: 10.7471/CT.2014.1683     Document Type: Article

References (34)

1. Modahl LE, Lai MM. Hepatitis delta virus: The molecular basis of laboratory diagnosis. Crit Rev Clin Lab Sci 2000; 37:45-92
2. Koytak ES, Yurdaydin C, Glenn JS. Hepatitis D. Curr Treat Options Gastroenterol 2007; 10(6):456-63
3. Di Bisceglie AM, Hoofnagle JH. Chronic viral hepatitis. In: Zakim D, Boyer TD, editors. Hepatology: a textbook of liver disease, 3rd ed., Hepatology: a textbook of liver disease, 2. Philadelphia: W.B. Saunders Co, 1996; 1299-329
4. Fattovich G, Boscaro S, Noventa F, et al. Infl uence of hepatitis delta virus on progression to cirrhosis in chronic hepatitis type B. J Infect Dis 1987; 155:931-5
5. Sagnelli E, Stroffolini T, Ascione A, et al. Decrease in HDV endemicity in Italy. J Hepatol 1997; 26:20-4
6. Rosina F, Conoscitore P, Cuppone R, et al. Changing pattern of chronic hepatitis D in southern Europe. Gastroenterol 1999; 117:161-6
7. Okten A, Demir K, Kaymakoǧlu S, et al. Etiologies of chronic hepatitis. Turk J Gastroenterol 1998; 9:113-5
8. Uzunalimoglu O, Yurdaydi{dotless}n C, Cetinkaya H, et al. Risk factors for hepatocellular carcinoma in Turkey. Dig Dis Sci 2001; 46(5):1022-8
9. Degertekin H, Yalcin K, Yakut M. The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: An analysis of clinical studies. Turk J Gastroenterol 2006; 17:25-34
10. Degertekin H, Yalcin K, Yakut M, et al. Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta-analysis. Liver Int 2008; 28(4): 494-8
11. Degertekin H, Yükselen V, Dursun M, et al. The seroepidemiology of delta hepatitis in Turkey. Turk J Gastroenterol 1999; 4: 319-23
12. Balik I, Onul M, Tekeli E, et al. Epidemiology and clinical outcome of hepatitis D virus infection in Turkey. Eur J Epidemiol 1991; 7:48-54
13. Yurdaydi{dotless}n C. Delta hepatitis in Turkey: Decreasing but not vanishing and still of concern. Turk J Gastroenterol 2006; 17:74-5
14. Farci P. Delta hepatitis: an update. J Hepatol 2003; 39(1): 212-9
15. Yamashiro T, Nagayama K, Enomoto N, et al. Quantitation of the level of hepatitis delta virus RNA in serum, by Real-Time Polymerase Chain Reaction - and its possible correlation with the clinical stage of liver disease. J Infect Dis 2004; 189(7): 1151-7
16. Degertekin H, Tuzcu A, Yalcin K. Horizontal transmission of HBV infection among students in Turkey. Public Health 2000; 114(5):411-2
17. Dursun M, Ertem M, Yi{dotless}lmaz S, et al. Prevalence of hepatitis B infection in the Southeastern region of Turkey: Comparision of risk factors for HBV infection in rural and Urban areas. Jpn J Infect Dis 2005; 58(1):15-9
18. Mutlu B, Meric M, Wilke A. Seroprevalance of hepatitis B and C virus, human immunodefi ciency virus and syphilis in the blood donors. Mikrobiyol Bul 2004; 38:445-8
19. Aydi{dotless}n F, Cubukcu K, Yetiskul S, et al. Retrospective evaluation of HBsAg, anti-HCV, anti-HIV and syphilis reagin antibody seropositivity in blood donors at the Trabzon Farabi Hospital. Mikrobiyol Bul 2002; 36(1):85-90
20. Gurol E, Saban C, Oral O, et al. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemiol 2006; 21:299-305
21. Dursun M, Gul K, Yi{dotless}lmaz S, et al. HBsAg and anti-HCV positivity ratios of volunteer blood donors admitted to blood centers in Diyarbaki{dotless}r. Akademik Gastroenteroloji Dergisi 2003; 283:130-3
22. Govindarajan S, Gupta S, Valinluck B, et al. Correlation of IgM anti-hepatitis D virus (HDV) to HDV-RNA in sera of chronic HDV. Hepatol 1989; 10:34-5
23. Buti M, Esteban R, Esteban JI, et al. Anti-HD IgM as a marker of chronic delta infection. J Hepatol 1987; 4(1):62-5
24. Wu JC, Chen TZ, Huang YS, et al. Natural history of hepatitis D viral superinfection: signifi cance of viremia detected by polymerase chain reaction. Gastroenterol 1995; 108(3): 796-802
25. Huang YH, Wu JC, Sheng WY, et al. Diagnostic value of anti-hepatitis D virus (HDV) antibodies revisited: a study of total and IgM anti-HDV compared with detection of HDVRNA by polymerase chain reaction. J Gastroenterol Hepatol 1998; 13(1):57-61
26. Inoue J, Takahashi M, Nishizawa T, et al. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia. J Med Virol 2005; 76(3):333-40
27. Sakugawa H, Nakasone H, Kawakami Y, et al. Determination of hepatitis delta virus HDV RNA in asymptomatic cases of HDV infection. Am J Gastroenterol 1997; 92(12):2232-6
28. Arakawa Y, Moriyama M, Taira M, et al. Molecular analysis of hepatitis D virus infection in Miyako Island, a small Japanese island. J Viral Hepat 2000; 7(5):375-81
29. Ozekinci T, Atmaca S, Akpolat N, et al. Evaluation of the correlation between Hepatitis D Virus (HDV) RNA positivity and HDV antibodies. Microbiyol Bul 2005; 39(3):345-9
30. Tsatsralt-Od B, Takahashi M, Nishizawa T, et al. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia. Arch Virol 2005; 150(12):2513-28
31. Doganay M, Patiroglu T, Utas C, et al. Comparison of HBsAg, anti-HCV and anti-HDV positivity in diverse groups. Microbiyol Bul 1993; 27(2):107-12
32. Wang SP, Ding H, Zhao OK. Studies on HDV and HCV infection in plasma donors with positive HBsAg. Zhoghua Yu Fang Yi Xue ZA Zhi 1994; 28(4):223-4
33. Celen MK, Ayaz C, Hosoglu S, et al. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey. Saudi Med J 2006; 27(5):617-20
34. Turkdogan MK, Bozkurt H, Uygan I, et al. Chronic hepatitis delta virus infection in Van region of eastern Turkey. Turk J Gastroenterol 2005; 16(1):17-20